{'fraction_non_alphanumeric': 0.04446978335233751, 'fraction_numerical': 0.029646522234891677, 'mean_word_length': 6.440677966101695, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hepatic miR‐33a/miR‐144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects

Abnormal cholesterol metabolism may contribute to the pathogenesis of non‐alcoholic steatohepatitis (NASH) and fibrosis. miR‐33 and miR‐144 regulate adenosine triphosphate binding cassette transporter (ABCA1) and other target genes involved in cholesterol efflux, fatty acid oxidation and inflammation. We explored relationships between non‐alcoholic fatty liver disease (NAFLD) and the hepatic expression of ABCA1/ABCG1, as well as other target genes regulated by miR‐33 (carnitine O‐octanoyltransferase, CROT and hydroxyacyl‐CoA‐dehydrogenase β‐subunit, HADHB) and miR‐144 (toll‐like receptor‐2, TLR2). Moreover, we evaluated whether the expression of these genes is correlated with miR‐33a/b and miR‐144 expression in Mexican individuals with morbid obesity.